共 13 条
[3]
Quantitative comparison of clopidogrel 600mg, prasugrel and ticagrelor, against clopidogrel 300mg on major adverse cardiovascular events and bleeding in coronary stenting: Synthesis of CURRENT-OASIS-7, TRITON-TIMI-38 and PLATO[J] . Sukhjinder S. Nijjer,Justin E. Davies,Darrel P. Francis.International Journal of Cardiology . 2011 (2)
[4]
Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
[J].
CIRCULATION,
2011, 124 (05)
:544-U78
Mahaffey, Kenneth W.
;
Wojdyla, Daniel M.
;
Carroll, Kevin
;
Becker, Richard C.
;
Storey, Robert F.
;
Angiolillo, Dominick J.
;
Held, Claes
;
Cannon, Christopher P.
;
James, Stefan
;
Pieper, Karen S.
;
Horrow, Jay
;
Harrington, Robert A.
;
Wallentin, Lars
.
[5]
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial[J] . Gregg W Stone,Bernhard Witzenbichler,Giulio Guagliumi,Jan Z Peruga,Bruce R Brodie,Dariusz Dudek,Ran Kornowski,Franz Hartmann,Bernard J Gersh,Stuart J Pocock,George Dangas,S Chiu Wong,Martin Fahy,Helen Parise,Roxana Mehran.The Lancet . 2011 (9784)
[6]
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J] . Lewis B. Morgenstern,J. Claude Hemphill,Craig Anderson,Kyra Becker,Joseph P. Broderick,E. Sander Connolly,Steven M. Greenberg,James N. Huang,R. Loch Macdonald,Steven R. Messé,Pamela H. Mitchell,Magdy Selim,Rafael J. Tamargo.Stroke . 2010 (9)
[7]
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial[J] . Shamir R Mehta,Jean-Francois Tanguay,John W Eikelboom,Sanjit S Jolly,Campbell D Joyner,Christopher B Granger,David P Faxon,Hans-Jurgen Rupprecht,Andrzej Budaj,Alvaro Avezum,Petr Widimsky,Philippe Gabriel Steg,Jean-Pierre Bassand,Gilles Montalescot,Carlos Macaya,Giuseppe Di
[8]
Impact of Femoral Vascular Closure Devices and Antithrombotic Therapy on Access Site Bleeding in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial[J] . Timothy A. Sanborn,Ramin Ebrahimi,Steven V. Manoukian,Brent T. McLaurin,David A. Cox,Frederick Feit,Martial Hamon,Roxana Mehran,Gregg W. Stone.Circulation: Cardiovascular Interventions . 2010 (1)
[9]
Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score[J] . Sumeet Subherwal,Richard G. Bach,Anita Y. Chen,Brian F. Gage,Sunil V. Rao,L Kristin Newby,Tracy Y. Wang,W Brian Gibler,E Magnus Ohman,Matthew T. Roe,Charles V. Pollack,Eric D. Peterson,Karen P. Alexander.Circulation . 2009 (14)
[10]
Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes: An Individual Patient–Level Combined Analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) Randomized Trials[J] . Shamir R. Mehta,William E. Boden,John W. Eikelboom,Marcus Flather,P Gabriel Steg,Alvaro Avezum,Rizwan Afzal,Leopoldo S. Piegas,David P. Faxon,Petr Widimsky,Andrzej Budaj